$38.40
2.386.61%
Last update: Oct 27, 4:17 PM
Hemab Therapeutics Holdings Inc
COAGNASDAQ
Hemab Therapeutics Hldgs (COAG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.78 | — |
| Actual | $-0.80 | $-23.98 |
| Surprise | -2.56% | — |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.51 | $-0.57 | $-0.54 | $-0.64 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.80 | $-0.78 | -2.56 % |
